Stockscreener 앱 받기
33.10
1.07%
0.35
시간 외 거래:
33.10
전일 마감가:
$32.75
열려 있는:
$32.62
하루 거래량:
9.01M
Relative Volume:
2.03
시가총액:
$14.08B
수익:
$2.27B
순이익/손실:
$1.15B
주가수익비율:
12.98
EPS:
2.55
순현금흐름:
$2.80B
1주 성능:
+1.91%
1개월 성능:
+7.29%
6개월 성능:
+26.29%
1년 성능:
+18.26%
1일 변동 폭
$32.37
$34.11
1주일 범위
$31.97
$34.11
52주 변동 폭
$24.05
$34.20
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
RPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
33.10 | 14.08B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.60 | 128.25B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.67 | 63.70B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
569.12 | 39.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
258.35 | 33.27B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
235.94 | 27.58B | 3.81B | -644.79M | -669.77M | -6.24 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
Royalty Pharma’s Earnings Call: Growth and Optimism - TipRanks
Schonfeld Strategic Advisors LLC Raises Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
AlTi Global Inc. Buys Shares of 387,567 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Earnings call transcript: Royalty Pharma Q1 2025 misses EPS estimates - Investing.com
Royalty Pharma plc SEC 10-Q Report - TradingView
Royalty Pharma earnings missed by $0.66, revenue fell short of estimates - Investing.com UK
Royalty Pharma Q1 2025 slides: double-digit growth drives raised guidance - Investing.com India
Royalty Pharma (NASDAQ:RPRX) Posts Q1 Sales In Line With Estimates - Yahoo Finance
Royalty Pharma (RPRX) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Royalty Pharma Reports First Quarter 2025 Results - TradingView
Cutter Capital Management LP Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Reports 17% Growth in Portfolio Receipts to $839 Million and Raises 2025 Financial Guidance - Nasdaq
AQR Capital Management LLC Boosts Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MML Investors Services LLC Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Price T Rowe Associates Inc. MD Cuts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Northern Trust Corp Acquires 376,619 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Dimensional Fund Advisors LP Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Caisse DE Depot ET Placement DU Quebec Makes New Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
ArrowMark Colorado Holdings LLC Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) Projected to Post Earnings on Thursday - MarketBeat
PDT Partners LLC Grows Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Hsbc Holdings PLC Sells 30,304 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Unlocking Q1 Potential of Royalty Pharma (RPRX): Exploring Wall Street Estimates for Key Metrics - Nasdaq
Royalty Pharma plc (NASDAQ:RPRX) Holdings Boosted by Regal Partners Ltd - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Tudor Investment Corp ET AL - MarketBeat
First Trust Advisors LP Decreases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Wells Fargo & Company MN Buys 15,790 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Moody’s upgrades Royalty Pharma’s rating, maintains stable outlook By Investing.com - Investing.com Nigeria
Moody’s upgrades Royalty Pharma’s rating, maintains stable outlook - Investing.com Australia
Walleye Capital LLC Buys Shares of 25,124 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Uniplan Investment Counsel Inc. Buys New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Dark Forest Capital Management LP - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by GMT Capital Corp - MarketBeat
Barclays PLC Acquires 54,421 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Declares $0.22 Quarterly Dividend - MarketBeat
Brokerages Set Royalty Pharma plc (NASDAQ:RPRX) Price Target at $42.50 - MarketBeat
Cerity Partners LLC Sells 15,537 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Canada Pension Plan Investment Board Buys 39,070 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Guggenheim Capital LLC Sells 82,768 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.88%
1.48%
자본화:
|
볼륨(24시간):